FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry T Kind, G Wohlgemuth, DY Lee, Y Lu, M Palazoglu, S Shahbaz, O Fiehn Analytical chemistry 81 (24), 10038-10048, 2009 | 1411 | 2009 |
LipidBlast in silico tandem mass spectrometry database for lipid identification T Kind, KH Liu, DY Lee, B DeFelice, JK Meissen, O Fiehn Nature methods 10 (8), 755-758, 2013 | 921 | 2013 |
Quality control for plant metabolomics: reporting MSI‐compliant studies O Fiehn, G Wohlgemuth, M Scholz, T Kind, DY Lee, Y Lu, S Moon, ... The Plant Journal 53 (4), 691-704, 2008 | 679 | 2008 |
Technical and clinical aspects of cortisol as a biochemical marker of chronic stress DY Lee, E Kim, MH Choi BMB reports 48 (4), 209, 2015 | 551 | 2015 |
High quality metabolomic data for Chlamydomonas reinhardtii DY Lee, O Fiehn Plant methods 4, 1-13, 2008 | 207 | 2008 |
Evaluation and optimization of metabolome sample preparation methods for Saccharomyces cerevisiae S Kim, DY Lee, G Wohlgemuth, HS Park, O Fiehn, KH Kim Analytical chemistry 85 (4), 2169-2176, 2013 | 154 | 2013 |
Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in Huntington mice AA Polyzos, DY Lee, R Datta, M Hauser, H Budworth, A Holt, S Mihalik, ... Cell metabolism 29 (6), 1258-1273. e11, 2019 | 118 | 2019 |
System response of metabolic networks in Chlamydomonas reinhardtii to total available ammonium DY Lee, JJ Park, DK Barupal, O Fiehn Molecular & Cellular Proteomics 11 (10), 973-988, 2012 | 118 | 2012 |
Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome NY Lee, SJ Yoon, DH Han, H Gupta, GS Youn, MJ Shin, YL Ham, ... Gut Microbes 11 (4), 882-899, 2020 | 96 | 2020 |
Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells Z Xun, DY Lee, J Lim, CA Canaria, A Barnebey, SM Yanonne, ... Mechanisms of ageing and development 133 (4), 176-185, 2012 | 95 | 2012 |
Suppression of somatic expansion delays the onset of pathophysiology in a mouse model of Huntington’s disease H Budworth, FR Harris, P Williams, DY Lee, A Holt, J Pahnke, B Szczesny, ... PLoS genetics 11 (8), e1005267, 2015 | 90 | 2015 |
Mass spectrometry—based metabolomics, analysis of metabolite-protein interactions, and imaging DY Lee, BP Bowen, TR Northen Biotechniques 49 (2), 557-565, 2010 | 89 | 2010 |
Evaluation of Sampling and Extraction Methodologies for the Global Metabolic Profiling of Saccharophagus degradans MH Shin, DY Lee, KH Liu, O Fiehn, KH Kim Analytical chemistry 82 (15), 6660-6666, 2010 | 89 | 2010 |
Scale-up of erythritol production by an osmophilic mutant of Candida magnoliae ES Koh, TH Lee, DY Lee, HJ Kim, YW Ryu, JH Seo Biotechnology letters 25, 2103-2105, 2003 | 79 | 2003 |
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis NY Lee, MJ Shin, GS Youn, SJ Yoon, YR Choi, HS Kim, H Gupta, SH Han, ... Clinical and Molecular Hepatology 27 (1), 110, 2021 | 74 | 2021 |
MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers MS Kim, HS Lee, YJ Kim, DY Lee, SG Kang, W Jin Cell Death & Differentiation 26 (12), 2594-2606, 2019 | 70 | 2019 |
Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty … JS Yu, GS Youn, J Choi, CH Kim, BY Kim, SJ Yang, JH Lee, TS Park, ... Clinical and Translational Medicine 11 (12), e634, 2021 | 67 | 2021 |
Comparative evaluation of extraction methods for simultaneous mass-spectrometric analysis of complex lipids and primary metabolites from human blood plasma DY Lee, T Kind, YR Yoon, O Fiehn, KH Liu Analytical and bioanalytical chemistry 406, 7275-7286, 2014 | 65 | 2014 |
Trinucleotide expansion in disease: why is there a length threshold? DY Lee, CT McMurray Current opinion in genetics & development 26, 131-140, 2014 | 62 | 2014 |
CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems Z Wu, D Lee, J Joo, JH Shin, W Kang, S Oh, DY Lee, SJ Lee, SS Yea, ... Antimicrobial agents and chemotherapy 57 (11), 5448-5456, 2013 | 59 | 2013 |